AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Respiratory & Autoimmunity, Cardiovascular & Metabolic Disease and Oncology.The Company is also active in inflammation, infection and neuroscience through numerous collaborations. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, please visit: www.astrazeneca.com.

BMS

Bristol Myers Squibb is a leading global biopharma company focused on discovering, developing and delivering innovative medicines for patients with serious diseases in areas including oncology, hematology, immunology, cardiovascular, fibrosis and neuroscience. Our employees work every day to transform patients’ lives through science.

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics have made Roche the leader in personalised healthcare – a strategy that aims to boldly transform and personalise healthcare to prevent, diagnose and treat each and every patient more effectively, while creating a more sustainable healthcare ecosystem.

MSD Australia

For 130 years, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases in pursuit of our mission to save and improve lives. MSD is a trade name of Merck & Co., Inc., with headquarters in Kenilworth, N.J., U.S.A. We demonstrate our commitment to patients and population health by increasing access to health care through far-reaching policies, programs and partnerships. Today, MSD continues to be at the forefront of research to prevent and treat diseases that threaten people and animals — including cancer, infectious diseases such as HIV and Ebola, and emerging animal diseases — as we aspire to be the premier research-intensive biopharmaceutical company in the world. For more information, visit www.msdoncology.com.au.

Takeda

Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Rare Diseases, Neuroscience and Gastroenterology (GI). We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.

Amgen

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Beigene

BeiGene is a global, commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing innovative medicines to improve treatment outcomes and access for patients worldwide. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal

Pfizer

One way or another, cancer touches all our lives. Which is why nothing is more personal, or more urgent, than our goal to find cures for cancer.

This motivates all of us at Pfizer, and we share that goal with healthcare providers, patient advocates, caregivers, biopharma companies, and everyone living with cancer.

Together, we’ve made meaningful progress, but our work is far from finished. The millions of people living with cancer and the millions more who will receive a diagnosis are the reason we continue to work relentlessly to deliver on our purpose: breakthroughs that change patients’ lives.

Maurice Blackburn

Maurice Blackburn is proud to be Australia’s leading social justice law firm. We’ve built a reputation on the unwavering belief that the law should serve everyone, not just those who can afford it.

We’re a national firm that spans Australia, with over 30 permanent offices supported by visiting offices across the states and territories. So, wherever you live, it is easy to access our lawyers. Each office is staffed by skilled local practitioners, who are backed by the resources of our entire network.

For over a century, Maurice Blackburn has won legal battles for individuals wo have been treated unfairly or injured. We provide accurate and confidential advice without unnecessary legal jargon, and we recognise the varying financial circumstances of our clients and offer a flexible fee policy. We treat every client who walks through our door with the sincerity and respect they deserve.

Bayer

Bayer is a global enterprise with core competencies in specialty and consumer healthcare. Through science and innovation, we are committed to the lives of people impacted by cancer. Bayer’s oncology research prioritises cutting-edge science across a range of therapeutic platforms to give patients and clinicians a multitude of options in the fight against cancer.